Navigation Links
Endo Pharmaceuticals Gives Update on Regulatory Status of Testosterone Undecanoate for Men with Hypogonadism
Date:9/2/2009

g this and past press releases of Endo Pharmaceuticals, is available at www.endo.com.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 regarding, among other things, the company's financial position, results of operations, market position, product development and business strategy, as well as estimates of future net sales, future expenses, future net income and future earnings per share. Statements including words such as "believes," "expects," "anticipates," "intends," "estimates," "plan," "will," "may," "intend," "guidance" or similar expressions are forward-looking statements. Because these statements reflect our current views, expectations and beliefs concerning future events, these forward-looking statements involve risks and uncertainties. Investors should note that many factors could affect our future financial results and could cause our actual results to differ materially from those expressed in forward-looking statements contained in this press release. These factors include, but are not limited to those detailed from time to time in our periodic reports filed with the Securities and Exchange Commission, including our current reports on Form 8-K, quarterly reports on Form 10-Q and annual reports on Form 10-K, particularly the discussion under the caption "Item 1A, RISK FACTORS" in our annual report on Form 10-K for the year ended December 31, 2008, which was filed with the Securities and Exchange Commission on March 2, 2009. The forward-looking statements in this press release are qualified by these risk factors. These are factors that, individually or in the aggregate, we think could cause our actual results to differ materially from expected and historical results. We assume no obligation to publicly update any forward-looking stat
'/>"/>

SOURCE Endo Pharmaceuticals
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4

Related medicine news :

1. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
2. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
3. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
4. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
5. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
6. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
7. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
8. Amylin Pharmaceuticals to Webcast Corporate Overview During 43rd Annual Meeting of the European Association for the Study of Diabetes
9. Major Pharma Clinical Case Studies From Amgen, AstraZeneca, GSK, Intermune, Cephalon Inc, Sunesis Pharmaceuticals and Dartmouth Medical School During Fall Clinical Focused Programs
10. Provectus Pharmaceuticals, Inc. releases summary results of phase 1 metastatic melanoma study
11. Class Settlement Could Result in Considerable Savings for Certain Consumers of Prescription Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/14/2009)... now provides in-home caregivers who have been certified by the ... therapy, caregiver, and hospice services to San Francisco Bay Area ... ... (PRWEB) December 14, 2009 -- Professional HealthCare at Home, the ... care, including nursing, rehab, personal caregiver and hospice services, has ...
(Date:12/14/2009)... NEW YORK, Dec. 14 Josie Raper, a 29 ... size) in six months with the help of the Dr. ... morning on the Joy Fit Club segment on NBC,s Today ... author Joy Bauer, airs twice a month and salutes those ... weight in 2007 and has kept it off for two ...
(Date:12/14/2009)... Dec. 14, 2009 Only about one in 2,000 people ... Wilcox was one of the unfortunate few. , Ms. Wilcox,s ... on, and even those problems were mistaken for blocked sinuses. ... right side of my nose," recalled the resident of Goldthwaite, ... Texas, Hill Country. "I felt a fullness, but I didn,t ...
(Date:12/14/2009)... published in the December issue of Mayo Clinic ... disorder myelofibrosis. This retrospective study is the largest ever ... Myelofibrosis is a serious disorder that disrupts the body,s ... scarring in the bone marrow, leading to severe anemia, ... , "In the past 20 years, management of ...
(Date:12/14/2009)... After frequent dislocations, ,sculpting, procedure may be long-term ... News) -- Patients who frequently experience shoulder dislocations ... new shoulder using bone and cartilage from cadavers, ... in the December issue of the American ... procedure could be an alternative to methods that ...
Breaking Medicine News(10 mins):Health News:Caregivers with Professional HealthCare at Home Now Certified by the Alzheimer's Association 2Health News:Size 24 to 6 in Just 6 Months: NBC's Today Show Celebrates Dr. Siegal's Cookie Diet Success Story on Joy Fit Club 2Health News:Size 24 to 6 in Just 6 Months: NBC's Today Show Celebrates Dr. Siegal's Cookie Diet Success Story on Joy Fit Club 3Health News:Size 24 to 6 in Just 6 Months: NBC's Today Show Celebrates Dr. Siegal's Cookie Diet Success Story on Joy Fit Club 4Health News:Minimally invasive surgery removes sinus tumor without facial disfiguration 2
... and out of the skin without pricking it makes for ... method which uses the application of an electric field// to ... the need for an injection. It could mean taking blood ... ,Researchers at the University of Texas, tried ...
... A experimental drug stopped the progression of cancer in ... effects. The drug phenoxodiol was given to patients with ... in a study done by the Ohio-based Cleveland Clinic. ... of drugs known as signal transduction inhibitors, all designed ...
... a new study shows that women with a ... cholesterol when they take oestrogen.// Previous research suggests that ... disease. Now doctors at Forest University have discovered a ... responds to HRT. ,An analysis of over 300 ...
... two days of public hearings to decide whether to ... doctor's prescription. A number of medications are being considered, ... But there are inconsistent views about how this could ... drug usage has risen in recent years, due, to ...
... their risk of heart disease by eating fish at least twice ... to those previously// seen in men. It is one of five ... ,The study of almost 98,000 women found those who ate ... heart disease by 32%, compared with women rarely ate fish. Women ...
... University of north Carolina at Chapel Hill, state about ... action. , The UNC scientists have ... that regulates production of the genetic messenger known as ... up the// process by which the information contained in DNA,is ...
Other Medicine News:
(Date:12/14/2009)... -- VION PHARMACEUTICALS, INC. (OTC Bulletin Board: ... complete response letter from the U.S. Food and ... Application ("NDA") for Onrigin(TM) (laromustine) injection submitted in ... FDA cannot approve the Company,s NDA in its ... issues. ,, Alan Kessman, Chief Executive Officer, responded, ...
(Date:12/14/2009)... 14 Authentidate Holding Corp. (Nasdaq: ... secure Health Information Exchange and workflow management ... the Carolinas ("HCC"), a home health agency, ... medical equipment supplier, have selected Authentidate,s Inscrybe® ... processes for the completion of patient care ...
(Date:12/14/2009)... Accuray Incorporated (Nasdaq: ARAY ), a global ... that the first CyberKnife® Robotic Radiosurgery System in ... of Liege. ,, The University Hospital in ... largest hospitals in Euregio, a cross-country region of ... range of cancer treatments, University Hospital of Liege ...
Breaking Medicine Technology:Vion Pharmaceuticals Receives Complete Response Letter for Onrigin(TM) From The U.S. Food And Drug Administration 2Vion Pharmaceuticals Receives Complete Response Letter for Onrigin(TM) From The U.S. Food And Drug Administration 3Home Care of the Carolinas and Alliance Medical, Inc. Select Authentidate's Inscrybe Healthcare to Improve Care Order Processing 2Home Care of the Carolinas and Alliance Medical, Inc. Select Authentidate's Inscrybe Healthcare to Improve Care Order Processing 3Home Care of the Carolinas and Alliance Medical, Inc. Select Authentidate's Inscrybe Healthcare to Improve Care Order Processing 4First CyberKnife in Belgium to be Installed at Leading University Hospital 2First CyberKnife in Belgium to be Installed at Leading University Hospital 3Patheon and JLL Partners Announce Litigation Settlement 6606 1Patheon and JLL Partners Announce Litigation Settlement 6606 2Patheon and JLL Partners Announce Litigation Settlement 6606 3Now you see it now you know you see it 62270 1Now you see it now you know you see it 62270 2Coverage of inexpensive drugs may increase length and quality of life after heart attack 62268 1Coverage of inexpensive drugs may increase length and quality of life after heart attack 62268 2
... Findings indicate early non-responders unlikely to subsequently,respond, ... benefit,from earlier change in treatment strategy, COLORADO ... data presented at the 2007 International Congress ... be assessed earlier than is presently thought, ...
... Time Reduced By an Average of More ... PARK, N.C., April 02, 2007 /PRNewswire/ --,Adding ... XL 24-Hour(TM) Extended-Release Tablets to,Parkinson's patients' existing ... patients to continue,their daily activities for a ...
Other Medicine Technology:New Data Show Early Non-Response to Antipsychotic Treatment May Be,Strong Predictor of Subsequent Non-Response for People with,Schizophrenia 2New Data Show Early Non-Response to Antipsychotic Treatment May Be,Strong Predictor of Subsequent Non-Response for People with,Schizophrenia 3New Data Show Early Non-Response to Antipsychotic Treatment May Be,Strong Predictor of Subsequent Non-Response for People with,Schizophrenia 4New Data Show Early Non-Response to Antipsychotic Treatment May Be,Strong Predictor of Subsequent Non-Response for People with,Schizophrenia 5New Data Show Early Non-Response to Antipsychotic Treatment May Be,Strong Predictor of Subsequent Non-Response for People with,Schizophrenia 6Once Daily, Extended-Release Ropinirole Improves Parkinson's,Symptoms in Patients not Optimally Controlled With Levodopa 2Once Daily, Extended-Release Ropinirole Improves Parkinson's,Symptoms in Patients not Optimally Controlled With Levodopa 3Once Daily, Extended-Release Ropinirole Improves Parkinson's,Symptoms in Patients not Optimally Controlled With Levodopa 4Once Daily, Extended-Release Ropinirole Improves Parkinson's,Symptoms in Patients not Optimally Controlled With Levodopa 5
... The Original LMA™ Airway., ,Launched in ... its use is now standard practice in ... patients worldwide the LMA Classic™ is a ... , ,The LMA Classic™ can be ...
... The Intubating LMA™ Airway. , ... or unexpected difficult airway, the LMA Fastrach™ ... without moving the head or neck. The ... attempts. , ,Selected by emergency teams ...
... The King LT™ is a superior, ... latest technological advances in materials and design ... The King LT™ emergency airway is a ... to provide emergency ventilation when direct laryngoscopy ...
... Soft amber latex. Available in even ... nasal airway maximizing patient comfort., ... way to maximize patient comfort while ... sensitivity. It is economically priced allowing ...
Medicine Products: